| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_213e7b98bce3a9d6be9936049694fa1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_674d1424c2f31f7cb1c99b2500c184e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47739f195c542079765e2bfbfdee4654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60dbbd8919372d22893af5dca865672b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2010-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0323208fd8eda4a97efae2470a07c0f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6009dbe6c9e927a0f7bb4822c22cd060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a346818ea2308e448c449c27b3ca52 |
| publicationDate |
2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012045894-A1 |
| titleOfInvention |
Compounds and compositions for the treatment of illnesses caused by the hepatitis b virus |
| abstract |
The invention relates to agents able to inhibit the expression of hepatitis B virus genes by inhibiting the maturation of the various RNAm of said virus using U1 RNAs, by means of interferent RNAs or synergistic combinations that include both inhibiting agents. The invention also relates to the use of said agents and to compositions for the treatment of illnesses caused by a Hepatitis B virus infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9127278-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9034841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9677076-B2 |
| priorityDate |
2010-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |